Latest Tricuspid valve Stories
For the first time in the United States, doctors at Henry Ford Hospital used a minimally invasive procedure to replace a failing, hard-to-reach heart valve with a new one - and placed it just outside the heart.
A potentially fatal bacterial disease of the heart, infective endocarditis frequently affects the heart's tricuspid valve, often resulting in permanent tissue damage.
An estimated 1.6 million Americans suffer moderate to severe leakage through their tricuspid valves, which are complex structures that allow blood to flow from the heart's upper right chamber to the ventricle.
A new study into the causes of leakage in one of the heart's most complex valve structures could lead to improved diagnosis and treatment of the condition.
INDIANAPOLIS, June 17, 2011 /PRNewswire/ -- The St. Francis Heart Center today (June 17, 2011) announced that it has performed the first post-FDA approval surgery in the United States using a new device for treating tricuspid valve disease.
David H. Adams, MD, Marie-JosÃ©e and Henry R. Kravis Professor and Chairman of the Department of Cardiothoracic Surgery at The Mount Sinai Medical Center, has performed the first implantation of the Medtronic Tri-Ad Semi-Flexible Tricuspid Annuloplasty Ring in the United States.
A state-of-the-art heart pump, designed to maintain a continuous flow of blood in end-stage cardiac patients with damage to the left side of the heart, also improves function on the right side of the heart.
MiCardia, which develops implantable devices for the treatment of heart disease, has announced that the FDA has granted 510(k) marketing clearance for its Dynaplasty Annuloplasty Band DR and Annuloplasty Ring DR.
- totally perplexed and mixed up.